BCL2 and Osteochondroma: The present study also performed IHC examination for different oncogenic proteins (p53, β-catenin, BCL2, pAKT, and survivin) and the biomarkers of chondrosarcoma (CEA, EMA, pan-K, and S-100) in BPOP and osteochondroma.